SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001161697-11-000268
Filing Date
2011-03-28
Accepted
2011-03-28 16:55:00
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR 12-31-2010 form_10-k.htm 10-K 1098933
2 CODE OF BUSINESS CONDUCT AND ETHICS ex_14-1.htm EX-14 21774
3 CONSENT OF FRIEDMAN LLP ex_23-1.htm EX-23 1473
4 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 5843
5 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 5838
6 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 2716
7 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 2706
8 chart.jpg GRAPHIC 31324
9 friedman_llp-logo.jpg GRAPHIC 20176
10 friedman_llp-address.gif GRAPHIC 12049
  Complete submission text file 0001161697-11-000268.txt   1228387
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32581 | Film No.: 11716396
SIC: 2834 Pharmaceutical Preparations